Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2014
12/10/2014CN104203944A 含新型香豆素衍生物的多荧光物质和使用其的诊断用led光源显微荧光定量生物传感器 The new coumarin derivatives containing multiple fluorescent material and using the same diagnostic led light microscopic fluorescence quantitative biosensors
12/10/2014CN104203939A 用作人呼吸道合胞病毒(rsv)抑制剂的二氨基嘧啶 As human respiratory syncytial virus (rsv) inhibitors diaminopyrimidine
12/10/2014CN104203928A 三嗪酮化合物及t型钙通道阻滞剂 Triazinone compounds and t-type calcium channel blockers
12/10/2014CN104203919A 可用作10a型磷酸二酯酶的抑制剂的杂环甲酰胺类 Can be used as a heterocyclic carboxamides 10a PDE inhibitors of phosphodiesterase type of
12/10/2014CN104203911A 芳氧基脲化合物和有害生物防除剂 Aryloxy urea compounds and a pest control agent
12/10/2014CN104203237A 脒取代的β-内酰胺化合物、其制备和作为抗菌剂的用途 Β- lactam substituted amidine compounds, their preparation and use as antibacterial agents
12/10/2014CN104203236A 杂环酰胺衍生物和含有其的药物 Heterocyclic amide derivatives and drugs containing the same
12/10/2014CN104193740A 作为沉默调节蛋白调节剂的苯并咪唑类和相关的类似物 As a sirtuin modulators benzimidazole class and related analogs
12/10/2014CN104193738A 一种基于苯并咪唑的电子传输化合物 An electron transport compound benzimidazole-based
12/10/2014CN103044414B 一种苯并噻唑衍生物及其制备方法和应用 One kind of benzothiazole derivatives and preparation method and application
12/10/2014CN102584808B 含噻吩基苯并噻唑单元的荧光材料的制备及应用方法 Preparation and application of thiophene-benzothiazole unit containing a fluorescent material
12/10/2014CN102348697B 磺酰胺衍生物 Sulfonamide derivatives
12/10/2014CN102311431B 一种制备无水β-氨曲南的方法 An anhydrous β- process for preparing aztreonam
12/10/2014CN102149680B 含氮芳族杂环化合物 Nitrogen-containing aromatic heterocyclic compound
12/09/2014US8907101 Sulfonamide derivatives
12/09/2014US8907099 Nitrocatechol derivatives as COMT inhibitors
12/09/2014US8907098 Inhibitors of sphingosine kinase
12/09/2014US8907092 Inhibitors of IAP
12/09/2014US8906947 Method for the separation and purification of epothilones
12/09/2014US8906941 Carboxamide compounds and their use as calpain inhibitors
12/09/2014US8906937 Flavivirus inhibitors and methods of their use
12/09/2014US8906922 Substituted triazoles useful as AXl inhibitors
12/09/2014US8906916 Pyrimidine derivatives as FAK inhibitors
12/09/2014US8906914 Ethylene diamine modulators of fatty acid hydrolase
12/09/2014US8906913 Azabicyclohexanes
12/09/2014US8906902 Antibacterial compounds
12/09/2014US8906900 PRMT5 inhibitors and uses thereof
12/09/2014US8906647 Diamide inhibitors of cytochrome P450
12/09/2014US8906591 Fluorine-free fused ring heteroaromatic photoacid generators and resist compositions containing the same
12/04/2014US20140357864 Process for the preparation of a statin precursor
12/04/2014US20140357687 Pyrazol-3-ones That Activate Pro-apoptotic BAX
12/04/2014US20140357684 Nol3 is a predictor of patient outcome
12/04/2014US20140357675 Substituted Phenylazole Derivatives
12/04/2014US20140357670 Dihydropyridinone mgat2 inhibitors
12/04/2014US20140357653 Chemical compounds
12/04/2014US20140357650 Novel fap inhibitors
12/04/2014US20140357633 Compounds for inhibiting the interaction of bcl2 with binding partners
12/04/2014US20140357629 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
12/04/2014US20140357626 Hetero-Bicyclic Derivatives As HCV Inhibitors
12/04/2014US20140357624 Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
12/04/2014US20140357612 Compounds for kinase modulation, and indications therefor
12/04/2014US20140356322 Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
12/04/2014US20140356292 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
12/02/2014US8901345 Process for preparation of optically active diamine derivative salt
12/02/2014US8901314 Substituted pyrazoles as N-type calcium channel blockers
12/02/2014US8901313 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/02/2014US8901308 Triazole compounds that modulate Hsp90 activity
12/02/2014US8901307 Chemical compounds 251
12/02/2014US8901306 Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
12/02/2014US8901301 Pyrrolo[2,3-]pyridine kinase inhibitors
12/02/2014US8901293 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
12/02/2014US8901156 Compounds and methods
12/02/2014US8901153 Pesticidal compositions and processes related thereto
12/02/2014US8901152 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
12/02/2014US8901147 Bi-heteroaryl compounds as Vps34 inhibitors
12/02/2014US8901145 Aminopyrimidine kinase inhibitors
12/02/2014US8901143 Pyrimidine derivatives
12/02/2014US8901138 Sulfoximine substituted quinazolines for pharmaceutical compositions
12/02/2014US8901121 Metalloenzyme inhibitor compounds
12/02/2014US8900728 Carbazole derivative, and light emitting element and light emitting device using the carbazole derivative
12/02/2014US8900604 Fatty acid conjugates of quetiapine, process for making and using the same
11/2014
11/27/2014US20140350059 Novel oxazolidinone derivatives
11/27/2014US20140350056 Trpv1 antagonists including dihydroxy substituent and uses thereof
11/27/2014US20140350055 Novel soft rock inhibitors
11/27/2014US20140350030 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same
11/27/2014US20140350026 Oxadiazole compound and preparation method thereof, pharmaceutical composition and use thereof
11/27/2014US20140350015 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
11/27/2014US20140350009 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
11/27/2014US20140349992 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/27/2014US20140349991 Chromone derivative having osteogenesis promoting effect
11/27/2014US20140349986 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
11/27/2014US20140349848 Fungicidal 4-substituted-3--1,2,4-oxadizol-5(4h)-one derivatives
11/27/2014US20140348748 Beta-amyloid imaging agents, methods of manufacture, and methods of use thereof
11/27/2014US20140348746 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof
11/25/2014US8895753 S1P receptor modulating agent
11/25/2014US8895752 Alkylsulfonyl-substituted thiazolide compounds
11/25/2014US8895750 Heteroaromatic compounds as BTK inhibitors
11/25/2014US8895749 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
11/25/2014US8895748 Synthesis for thiazolidinedione compounds
11/25/2014US8895741 Process for the synthesis of biaryl oxazolidinones
11/25/2014US8895733 Triazine-oxadiazoles
11/25/2014US8895590 Epothilone compounds, preparation method and use thereof
11/25/2014US8895589 Pyridinyl amides as P2X3 and P2X2/3 inhibitors
11/25/2014US8895587 Insecticidal compounds based on arylthioacetamide derivatives
11/25/2014US8895573 Phenoxy-substituted pyrimidines as opioid receptor modulators
11/25/2014US8895571 Isoindolinone and pyrrolopyridinone derivatives as Akt inhibitors
11/25/2014US8895566 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
11/25/2014US8895563 Human protein tyrosine phosphatase inhibitors and methods of use
11/25/2014US8895559 Quinoxalines derivatives and pharmaceutical compositions and kits
11/25/2014US8895558 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
11/25/2014US8895548 Pharmaceutical composition for treating alzheimer's disease
11/25/2014US8895535 Pyrrolidinones as MetAP-2 inhibitors
11/25/2014US8895313 Ligands for aggregated tau molecules
11/25/2014US8895159 Aromatic amine derivative and organic electroluminescence device using the same
11/25/2014US8895035 Alkoxyimino derivative and pest control agent
11/20/2014US20140343292 Process for the preparation of a thioprecursor for statins
11/20/2014US20140343278 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343277 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343077 Hepatitis c inhibitor compounds
11/20/2014US20140343073 Process for preparation of amorphous form of dasatinib
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 628